• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials.

作者信息

Sashegyi Andreas, Zhang Yawei, Lin Yong, Binder Polina, Ferry David

机构信息

a Eli Lilly and Company , Indianapolis , IN , USA.

b Eli Lilly and Company , Bridgewater , NJ , USA.

出版信息

J Chemother. 2017 Feb;29(1):62-64. doi: 10.1080/1120009X.2015.1113023. Epub 2016 Feb 6.

DOI:10.1080/1120009X.2015.1113023
PMID:27077927
Abstract
摘要

相似文献

1
Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials.评论：接受雷莫西尤单抗治疗的癌症患者发生胃肠道穿孔的风险：一项随机对照试验的荟萃分析。
J Chemother. 2017 Feb;29(1):62-64. doi: 10.1080/1120009X.2015.1113023. Epub 2016 Feb 6.
2
Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials.接受雷莫西尤单抗的癌症患者发生胃肠道穿孔的风险：一项随机对照试验的荟萃分析
J Chemother. 2016 Aug;28(4):328-34. doi: 10.1179/1973947815Y.0000000053.
3
Ramucirumab: targeting angiogenesis in the treatment of gastric cancer.雷莫西尤单抗：靶向血管生成用于治疗胃癌
Immunotherapy. 2014;6(11):1177-86. doi: 10.2217/imt.14.85.
4
Clinical pharmacokinetics and pharmacodynamics of ramucirumab in the treatment of colorectal cancer.雷莫西尤单抗治疗结直肠癌的临床药代动力学和药效学
Expert Opin Drug Metab Toxicol. 2016;12(4):449-56. doi: 10.1517/17425255.2016.1156084. Epub 2016 Mar 10.
5
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies.靶向治疗的癌症患者的心脏毒性发生率和风险。
Cancer Treat Rev. 2017 Sep;59:123-131. doi: 10.1016/j.ctrv.2017.07.006. Epub 2017 Jul 28.
6
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis.靶向VEGFR-2治疗转移性胃癌：基于文献的Meta分析结果
Cancer Invest. 2017 Mar 16;35(3):187-194. doi: 10.1080/07357907.2016.1276185. Epub 2017 Feb 6.
7
Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancer.雷莫西尤单抗，一种针对跨膜信号酪氨酸激酶VEGFR-2的全人源单克隆抗体，用于癌症的潜在治疗。
Curr Opin Investig Drugs. 2009 Jun;10(6):597-605.
8
Risk of hematological toxicities in patients with solid tumors treated with ramucirumab: a meta-analysis.雷莫西尤单抗治疗实体瘤患者血液学毒性的风险：一项荟萃分析。
Future Oncol. 2015;11(21):2949-61. doi: 10.2217/fon.15.178. Epub 2015 Sep 30.
9
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.雷莫芦单抗单药治疗既往治疗的晚期胃或胃食管结合部腺癌（REGARD）：一项国际、随机、多中心、安慰剂对照、3 期临床试验。
Lancet. 2014 Jan 4;383(9911):31-39. doi: 10.1016/S0140-6736(13)61719-5. Epub 2013 Oct 3.
10
U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy.美国食品药品监督管理局批准摘要：雷莫西尤单抗用于治疗铂类化疗期间或之后疾病进展的转移性非小细胞肺癌。
Oncologist. 2015 Nov;20(11):1320-5. doi: 10.1634/theoncologist.2015-0221. Epub 2015 Oct 7.

引用本文的文献

1
Diverticular perforation of terminal ileum associated with chemotherapy for non-small cell lung carcinoma: a case report.非小细胞肺癌化疗相关的回肠末端憩室穿孔：一例报告
J Surg Case Rep. 2023 Apr 12;2023(4):rjad179. doi: 10.1093/jscr/rjad179. eCollection 2023 Apr.
2
Delayed pharyngocutaneous fistula caused by molecular targeted therapy: a case report.分子靶向治疗导致的咽皮瘘延迟发生：一例报告。
J Med Case Rep. 2022 Oct 22;16(1):383. doi: 10.1186/s13256-022-03621-2.
3
Ramucirumab-Induced Hepatocellular Carcinoma Rupture and Gastrointestinal Perforation.
雷莫西尤单抗诱发的肝细胞癌破裂和胃肠道穿孔。
Am J Case Rep. 2021 Feb 18;22:e929493. doi: 10.12659/AJCR.929493.
4
Bronchobiliary fistula after ramucirumab treatment for advanced gastric cancer: A case report.雷莫西尤单抗治疗晚期胃癌后发生支气管胆管瘘：一例报告
World J Clin Cases. 2019 Oct 6;7(19):3039-3046. doi: 10.12998/wjcc.v7.i19.3039.
5
A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis.1例伴有小肠转移的胃癌患者发生雷莫西尤单抗相关胃肠道穿孔。
Surg Case Rep. 2017 Dec 19;3(1):127. doi: 10.1186/s40792-017-0399-7.